Skip to main content
Clinical Trials/NCT03858543
NCT03858543
Completed
Early Phase 1

Fractional Laser Assisted Delivery of Sculptra® for the Treatment of Striae: FADeS Trial

Henry Ford Health System1 site in 1 country10 target enrollmentStarted: July 15, 2019Last updated:

Overview

Phase
Early Phase 1
Status
Completed
Enrollment
10
Locations
1
Primary Endpoint
Change in Stretch Mark Size

Overview

Brief Summary

This study evaluates the efficacy of treatment of striae distensae using the combined modality of fractional laser and poly-L lactic acid (Sculptra).

Detailed Description

Striae Distensae (SD) is a form of scarring that can oftentimes be quite disfiguring and emotionally distressing to individuals.

Fractional laser therapy has been used by doctors to treat stretch marks by stimulating collagen growth.

Poly-L lactic acid also promotes collagen growth in the areas injected.

The combination of laser and poly-L lactic acid might provide the optimal treatment modality for SD by decreasing the appearance of atrophic scars.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subject has bilateral striae alba
  • Subject has stable body weight for at least 6 months with Fitzpatrick skin type 1-4

Exclusion Criteria

  • Subject has striae rubra
  • History of adverse effects to phototherapy
  • Subject has single sided lesions
  • Subject has immunosuppression
  • Subject has radiation therapy to the study area
  • Subject has topical or oral steroid use or chemotherapy within the last 6 months
  • History of keloids or hypertrophic scar

Arms & Interventions

Fractional laser treatment & Poly-L Lactic Acid (Sculptra)

Experimental

One Fractional laser treatment on half of the body with Sciton Laser and Scluptra

Intervention: Poly-L Lactic Acid (Drug)

Fractional laser treatment & Poly-L Lactic Acid (Sculptra)

Experimental

One Fractional laser treatment on half of the body with Sciton Laser and Scluptra

Intervention: Fractional laser treatment (Device)

Fractional laser treatment

Active Comparator

One Fractional laser treatment on half of the body with Sciton Laser

Intervention: Fractional laser treatment (Device)

Outcomes

Primary Outcomes

Change in Stretch Mark Size

Time Frame: Baseline (Pre-treatment) vs. 3 Months, 4 Months, 5 Months, 6 Months

Modified Manchester Scar Scale was used to assess stretch mark reduction compared to pre-treatment photographs. The range of each subscale is between 4-26. A higher value represents a worse outcome. A value of 26 is the maximum score and represents the worst outcome. A value of 4 is the minimum score and represents the best outcome. Subscales are then summed to compute a total score.

Secondary Outcomes

  • Treatments Superiority Assessment(6 Months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

aamir siddiqui

Division Head - Plastic & Reconstruction Surgery

Henry Ford Health System

Study Sites (1)

Loading locations...

Similar Trials